Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation
- PMID: 31410983
- DOI: 10.1111/jth.14578
Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation
Comment in
-
The prothrombin time ratio is not a more effective marker for evaluating sepsis-induced coagulopathy than fibrin-related markers.J Thromb Haemost. 2020 Jun;18(6):1506-1507. doi: 10.1111/jth.14766. J Thromb Haemost. 2020. PMID: 32496020 No abstract available.
-
RE: The prothrombin time ratio is not a more effective marker for evaluating sepsis-induced coagulopathy than fibrin-related markers: Response to the Letter-to-the-Editor by Dr Wada.J Thromb Haemost. 2020 Jun;18(6):1507-1509. doi: 10.1111/jth.14799. J Thromb Haemost. 2020. PMID: 32496021 No abstract available.
References
REFERENCES
-
- Taylor FB, Toh CH, Hoots WK, WadaHLeviM et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327-30.
-
- van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17:407-20.
-
- Iba T, Levy JH. Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis. J Thromb Haemost. 2018;16:231-41.
-
- Gando S, Levi M, Toh CH. Disseminated intravascular coagulation. Nat Rev Dis Primers. 2016;2:16037.
-
- Umemura Y, Yamakawa K, Ogura H, Yuhara H, Fujimi S. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials. J Thromb Haemost. 2016;14:518-30.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical